Functionalized nanomedicines for co-targeting of multiple pathways to efficiently treat thyroid cancer: prospects and challenges
Haidi Chu, Dong Wang · 2026
Read Functionalized nanomedicines for co-targeting of multiple pathways to efficiently treat thyroid cancer: prospects and challenges by Haidi Chu, Dong Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218989.txt.
Description
Haidi Chu and Dong Wang review functionalized nanomedicines that target several pathways at once in thyroid cancer. Thyroid tumors adapt and survive through complex signaling networks, so single target drugs often fall short. Redundant pathways, compensatory responses, and systemic toxicity limit conventional delivery, and nanomedicines promise finer tumor specificity with controlled release.
The review maps the central pathways that drive growth, survival, vessel formation, and cell death in thyroid cancer. Modern nanomedicine designs that hit two or more pathways together are outlined in detail. Benefits and hurdles are weighed, from targeting precision to safety and manufacture. The authors position multi pathway co targeting as a distinct advance over prior single target reviews.
Catalog record
| CREATOR | Haidi Chu, Dong Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |